Fig. 4
From: Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
The outlook for TCR-T development. A Amplifications of TCR-Ts in conjunction with the main existing immunotherapies to improve efficacy. B Amplifications of TCR-Ts in conjunction with some new drugs. C Some derivatives of TCR-T: immune-mobilizing monoclonal TCRs Against Cancer (ImmTACs) are not restricted by fixed HLA molecular typing; and Super TCR-T is able to recognize multiple antigenic epitopes of a tumor cell